Aktienanalyse zu Celsius Holdings, Inc. (CELH)CELHCelsius Holdings, Inc.

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Celsius Holdings Inc is currently priced at $28.58, which is below the average analyst price target of $42, indicating potential upside. However, the stock has a high forward P/E of 16.86, suggesting it may be overvalued given its recent performance, with a year-to-date change of -40.15%. Additionally, the RSI is at 65.16, indicating it is nearing overbought territory. The main risk is the recent class action lawsuit, which could negatively impact investor sentiment.

1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.